UK biotech using AI to discover drug targets for cardiovascular diseases.
| Date | Round | Amount |
|---|---|---|
| Jul 2022 | Pre Seed Cambridge biotech CardiaTec raised a 1.4M pound (1.6M euro) pre-seed led by Laidlaw Scholars Ventures and APEX Ventures to develop AI-driven cardiovascular drug discovery. | $1.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.